Search

Displaying results 3151 - 3160 of 5392 in total
  1. Drug

    Salclobuzic acid

    go.drugbank.com/drugs/DB19931
    Experimental

    Salclobuzic acid has a monoisotopic molecular weight of 257.05 Da.

  2. Drug

    Clamidoxic acid

    go.drugbank.com/drugs/DB19938
    Experimental

    Clamidoxic acid has a monoisotopic molecular weight of 339.01 Da.

  3. Drug

    Sulfaloxic acid

    go.drugbank.com/drugs/DB19971
    Experimental

    Sulfaloxic acid has a monoisotopic molecular weight of 393.06 Da.

  4. Drug

    Sorbitan monopalmitate

    go.drugbank.com/drugs/DB20199
    Experimental

    Sorbitan monopalmitate has a monoisotopic molecular weight of 402.3 Da.

  5. Drug

    Napsagatran anhydrous

    go.drugbank.com/drugs/DB20288
    Experimental

    Napsagatran anhydrous has a monoisotopic molecular weight of 558.23 Da.

  6. Drug

    Olpadronic acid

    go.drugbank.com/drugs/DB20303
    Investigational

    Olpadronic acid has a monoisotopic molecular weight of 263.03 Da.

  7. Drug

    Lesopitron

    go.drugbank.com/drugs/DB04970
    Experimental

    Lesopitron is an anxiolytic with pre- and post-synaptic 5-HT1A agonist activity, which is under development by Esteve.

  8. Drug

    Azaperone

    go.drugbank.com/drugs/DB11376
    InvestigationalVet approved

    Azaperone is a pyridinylpiperazine and butyrophenone agent that is capable of eliciting neuroleptic sedative and antiemetic effects. It is subsequently employed predominantly as a veterinary tranquilizer and mainly for pigs and elephants...

    Categories: Dopamine D2 Receptor Antagonists
  9. Drug

    Mianserin

    go.drugbank.com/drugs/DB06148
    ApprovedWithdrawn

    A tetracyclic compound with antidepressant effects. Mianserin was previously available internationally, however in most markets it has been phased out in favour of mirtazapine.

    Categories: Dopamine D2 Receptor Antagonists
  10. Drug

    Faricimab

    go.drugbank.com/drugs/DB15303
    ApprovedInvestigational

    Retinal vascular diseases (RVDs) such as diabetic macular edema (DME), age-related macular degeneration (AMD), and retinal vein occlusion (RVO) are typically caused by retinal ischemia and subsequent neovascularization (NV). Vascular end...